Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition

British Journal of Cancer

Volumn 100, Issue 11, 2009, Pages 1817-1823

  Travis, R C ^a   Spencer, E A ^a   Allen, N E ^a   Appleby, P N ^a   Roddam, A W ^a   Overvad, K ^b   Johnsen, N F ^c   Olsen, A ^c   Kaaks, R ^d   Linseisen, J ^d   Boeing, H ^e   Nothlings U ^e   Bueno De Mesquita, H B ^f   Ros, M M ^f   Sacerdote, C ^g   Palli, D ^h   Tumino, R ⁱ   Berrino, F ^j   Trichopoulou, A ^k   Dilis, V ^k   Trichopoulos, D ^l,m   Chirlaque, M D ⁿ   Ardanaz, E ^o,p   Larranaga, N ^q   Gonzalez, C ^r   Suarez L R ^s   Sanchez M J ^p,t   Bingham, S ^u   Khaw, K T ^u   Hallmans, G ^v   Stattin, P ^v   Rinaldi, S ^w   Slimani, N ^w   Jenab, M ^w   Riboli, E ^x   Key, T J ^a   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^f NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^g ISI FOUNDATION   (Italy)

^h CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

ⁱ CIVILE M P AREZZO HOSPITAL   (Italy)

^j NATIONAL CANCER INSTITUTE   (Italy)

^k UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^l HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^m HELLENIC HEALTH FOUNDATION   (Greece)

ⁿ DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^o INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^p CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^q Basque Government   (Spain)

^r CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^s Health Information Section   (Spain)

^t ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^u UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^v UMEÅ UNIVERSITY   (Sweden)

^w INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^x IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Genistein; Isoflavone; Lignan; Plasma; Prospective; Prostate cancer

Indexed keywords

DAIDZEIN; ENTERODIOL; ENTEROLACTONE; EQUOL; GENISTEIN; ISOFLAVONE; LIGNAN; PHYTOESTROGEN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; EUROPE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PLASMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK ASSESSMENT; RISK REDUCTION; TANDEM MASS SPECTROMETRY;

CASE-CONTROL STUDIES; DIET; EUROPE; GENISTEIN; HUMANS; MALE; MIDDLE AGED; PHYTOESTROGENS; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 67349200636     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605073     Document Type: Article

References (34)

1. Allen NE, Sauvaget C, Roddam AW, Appleby P, Nagano J, Suzuki G, Key TJ, Koyama K (2004) A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control 15: 911-920
2. Bingham SA, Atkinson C, Liggins J, Bluck L, Coward A (1998) Phyto-oestrogens: where are we now? Br J Nutr 79: 393-406
3. Bylund A, Zhang J-X, Bergh A, Damber JE, Widmark A, Johansson A, Adlercreutz H, Aman P, Shepherd MJ, Hallmans G (2000) Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate 42: 304-314
4. Friedenreich C, Cust A, Lahmann PH, Steindorf K, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S, Linseisen J, Rohrmann S, Pischon T, Schulz M, Tjonneland A, Johnsen NF, Overvad K, Mendez M, Arguelles MV, Garcia CM, Larranaga N, Chirlaque MD, Ardanaz E, Bingham S, Khaw KT, Allen N, Key T, Trichopoulou A, Dilis V, Trichopoulos D, Pala V, Palli D, Tumino R, Panico S, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Monninkhof E, Berglund G, Manjer J, Slimani N, Ferrari P, Kaaks R, Riboli E (2007) Physical activity and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Int J Cancer 121: 347-355
5. Goetzel MA, Van Veldhuizen PJ, Thrasher JB (2007) Effects of soy phyto-oestrogens on the prostate. Prostate Cancer Prostatic Dis 10: 216-223
6. Grace PB, Mistry NS, Carter MH, Leathem AJ, Teale P (2007) High throughput quantification of phyto-oestrogens in human urine and serum using liquid chromatography/tandem mass spectrometry (LC-MS/ MS). J Chromatogr B Analyt Technol Biomed Life Sci 853: 138-146
7. Jacobsen BK, Knutsen SF, Fraser GE (1998) Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control 9: 553-557
8. Keinan-Boker L, Peeters PH, Mulligan AA, Navarro C, Slimani N, Mattisson I, Lundin E, McTaggart A, Allen NE, Overvad K, Tjønneland A, Clavel-Chapelon F, Linseisen J, Haftenberger M, Lagiou P, Kalapothaki V, Evangelista A, Frasca G, Bueno-de-Mesquita HB, van der Schouw YT, Engeset D, Skeie G, Tormo MJ, Ardanaz E, Charrondière UR, Riboli E (2002) Soy product consumption in 10 European countries: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 5: 1217-1226
9. Kilkkinen A, Virtamo J, Virtanen MJ, Adlercreutz H, Albanes D, Pietinen P (2003) Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study. Cancer Epidemiol Biomarkers Prev 12: 1209-1212
10. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S (2007) Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev 16: 538-545
11. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA (2000a) Daidzein and genistein contents of vegetables. Br J Nutr 84: 717-725
12. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA (2000b) Daidzein and genistein content of fruits and nuts. J Nutr Biochem 11: 326-331
13. Liggins J, Mulligan A, Runswick S, Bingham SA (2002) Daidzein and genistein content of cereals. Eur J Clin Nutr 56: 961-966
14. Low YL, Taylor JI, Grace PB, Mulligan AA, Welch AA, Scollen S, Dunning AM, Luben RN, Khaw KT, Day NE, Wareham NJ, Bingham SA (2006) Phyto-oestrogen exposure, polymorphisms in COMT, CYP19, ESR1, and SHBG genes, and their associations with prostate cancer risk. Nutr Cancer 56: 31-39
15. Magee PJ, Rowland IR (2004) Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 91: 513-531
16. McCann MJ, Gill CI, McGlynn H, Rowland IR (2005) Role of mammalian lignans in the prevention and treatment of prostate cancer. Nutr Cancer 52: 1 -14
17. McCarty MF (2006) Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. Med Hypotheses 66: 1093-1114
18. McCormick DL, Johnson WD, Bosland MC, Lubet RA, Steele VE (2007) Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor. Nutr Cancer 57: 184-193
19. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M, Masamune Y (2001) Interaction of phyto-oestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 24: 351-356
20. Mueller SO, Simon S, Chae K, Metzler M, Korach KS (2004) Phyto-oestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 80: 14-25
21. Nomura AM, Hankin JH, Lee J, Stemmermann GN (2004) Cohort study of tofu intake and prostate cancer: no apparent association. Cancer Epidemiol Biomarkers Prev 13: 2277-2279
22. Ozasa K, Nakao M, Watanabe Y, Hayashi K, Miki T, Mikami K, Mori M, Sakauchi F, Washio M, Ito Y, Suzuki K, Wakai K, Tamakoshi A (2004) Serum phyto-oestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci 95: 65-71
23. Perabo FGE, Von Low EC, Ellinger J, von Rucker A, Muller SC, Bastian PJ (2008) Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis 11: 6-12
24. Peeters PH, Slimani N, van der Schouw YT, Grace PB, Navarro C, Tjonneland A, Olsen A, Clavel-Chapelon F, Touillaud M, Boutron-Ruault MC, Jenab M, Kaaks R, Linseisen J, Trichopoulou A, Trichopoulos D, Dilis V, Boeing H, Weikert C, Overvad K, Pala V, Palli D, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HB, van Gils CH, Skeie G, Jakszyn P, Hallmans G, Berglund G, Key TJ, Travis R, Riboli E, Bingham SA (2007) Variations in plasma phyto-oestrogen concentrations in European adults. J Nutr 137: 1294-1300
25. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondière UR, Hémon B, Casagrande C, Vignat J, Overvad K, Tjoønneland A, Clavel-Chapelon F, Thiébaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, González CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5: 1113-1124
26. Ricke WA, Wang Y, Cunha GR (2007) Steroid hormones and carcinogenesis of the prostate: the role of estrogens. Differentiation 75: 871-882
27. Rosner B (1982) A generalization of the paired t-test. Appl Stat 31: 9-13
28. Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G, Cassidy A (2003) Bioavailability of phyto-oestrogens. Br J Nutr 89: S45-S58
29. Setchell KD, Brown NM, Lydeking-Olsen E (2002) The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132: 3577-3584
30. Severson RK, Nomura AM, Grove JS, Stemmermann GN (1989) A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49: 1857-1860
31. StataCorp (2005) Stata Statistical Software: Release 9. StataCorp LP: College Station, TX
32. Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M (2002) Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study. Int J Cancer 99: 124-129
33. Stattin P, Bylund A, Biessy C, Kaaks R, Hallmans G, Adlercreutz H (2004) Prospective study of plasma enterolactone and prostate cancer risk (Sweden). Cancer Causes Control 15: 1095-1102
34. Ward H, Chapelais G, Kuhnle GGC, Luben R, Khaw KT, Bingham S (2008) Lack of prospective associations between plasma and urinary phytoes-trogens and risk of prostate or colorectal cancer in the European Prospective Investigation into Cancer-Norfolk Study. Cancer Epidemiol Biomarkers Prev 17: 2891-2893